Your browser doesn't support javascript.
loading
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies.
Kriegsmann, Mark; Roessler, Stephanie; Kriegsmann, Katharina; Renner, Marcus; Longuespée, Rémi; Albrecht, Thomas; Loeffler, Moritz; Singer, Stephan; Mehrabi, Arianeb; Vogel, Monika Nadja; Pathil, Anita; Köhler, Bruno; Springfeld, Christoph; Rupp, Christian; Weiss, Karl Heinz; Goeppert, Benjamin.
Afiliação
  • Kriegsmann M; Institute of Pathology, University Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
  • Roessler S; Institute of Pathology, University Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
  • Kriegsmann K; Department of Rheumatology, Oncology and Hematology, University of Heidelberg, Heidelberg, Germany.
  • Renner M; Institute of Pathology, University Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
  • Longuespée R; Institute of Pathology, University Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
  • Albrecht T; Institute of Pathology, University Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
  • Loeffler M; Institute of Pathology, University Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
  • Singer S; Institute of Pathology, University Heidelberg, Im Neuenheimer Feld 224, Heidelberg, Germany.
  • Mehrabi A; Department of General Visceral and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, Heidelberg, Germany.
  • Vogel MN; Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany.
  • Pathil A; Diagnostic and Interventional Radiology, Thoraxklinik at University Hospital of Heidelberg, Heidelberg, Germany.
  • Köhler B; Department of Internal Medicine IV, Gastroenterology and Hepatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany.
  • Springfeld C; Department of Medical Oncology, University Hospital Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany.
  • Rupp C; Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany.
  • Weiss KH; Department of Medical Oncology, University Hospital Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany.
  • Goeppert B; Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany.
BMC Cancer ; 19(1): 72, 2019 Jan 15.
Article em En | MEDLINE | ID: mdl-30646854
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Tumor de Klatskin / Antígeno B7-H1 / Anticorpos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Tumor de Klatskin / Antígeno B7-H1 / Anticorpos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha